ONCOTECH, INC.

Company Information

Company Name
ONCOTECH, INC.
Address
ONCOTECH, INC.
1791 KAISER AVE
IRVINE, CA, 92614
Phone
1 949-474-9262
URL
n/a
DUNS
n/a
Number of Employees
n/a
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N

Award Totals

PROGRAM/PHASE
AWARD AMOUNT ($)
NUMBER OF AWARDS
SBIR Phase I
$349,354.00
5
Chart code to be here

Award List

  1. THE LONG-TERM GOAL OF THIS PROJECT IS THE DEVELOPMENT OF NEWTHERAPEUTIC STRATEGIES FOR THE CIRCUMVENTION OF DRUG RESISTANCE IN HUMAN NEOPLASMS.

    Amount: $50,000.00

    THE LONG-TERM GOAL OF THIS PROJECT IS THE DEVELOPMENT OF NEWTHERAPEUTIC STRATEGIES FOR THE CIRCUMVENTION OF DRUG RESISTANCE IN HUMAN NEOPLASMS. BY FIRST ESTABLISHING THE ABILITY OF THE DIFFERENTIAL ST ...

    SBIR Phase I 1986 Department of Health and Human Services
  2. Development of a Therapeutic TNF Degradation Product

    Amount: $50,000.00

    Recombinant human tumor necrosis factor-alpha (TNF) has had only modest success in clinical trials, in part because of dose limiting toxicities. To fully realize TNF's clinical activity, it will be ne ...

    SBIR Phase I 1993 Department of Health and Human Services
  3. Development of an MDR-1 Resistance-Reversal Assay

    Amount: $50,000.00

    Currently, assays for MDR-1 expression are for research purposes only. This study will determine if measurement of MDR-1 expression by flow cytometry can be performed as a routine clinical assay, and ...

    SBIR Phase I 1993 Department of Health and Human Services
  4. A New High Throughput Assay for Human MDR1 Substrates

    Amount: $99,653.00

    DESCRIPTION (PROVIDED BY APPLICANT): We propose to develop and validate a high throughput assay for cost/time-efficient screening and characterizing of compounds transported by human ...

    SBIR Phase I 2001 Department of Health and Human Services
  5. GENOMICS SCREENING FOR ANTIANGIOGENESIS DRUGS

    Amount: $99,701.00

    DESCRIPTION (provided by applicant): We will develop a system for testing new anti-angiogenesis compounds using vascular endothelial cells (VEC) derived from fresh human tumors. In Phase I we will val ...

    SBIR Phase I 2002 Department of Health and Human Services

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government